Patent details

EP3154565 Title: TREATMENT OF IMMUNE DISORDERS

Basic Information

Publication number:
EP3154565
PCT Application Number:
EP2015062138
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157284571
PCT Publication Number:
WO2015189063
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF IMMUNE DISORDERS
French Title of Invention:
TRAITEMENT DE TROUBLES IMMUNITAIRES
German Title of Invention:
BEHANDLUNG VON IMMUNERKRANKUNGEN
SPC Number:

Dates

Filing date:
01/06/2015
Grant date:
03/05/2023
EP Publication Date:
19/04/2017
PCT Publication Date:
17/12/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/05/2023
EP B1 Publication Date:
03/05/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/06/2023
Expiration date:
01/06/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/04/2023
 
 

Name:
Mesoblast International Sàrl
Address:
Route de Pré-Bois 20, 1217 Meyrin, Switzerland (CH)

Inventor

1

Name:
ITESCU, Silviu
Address:
Australia (AU)

2

Name:
SIMMONS, Paul
Address:
Australia (AU)

Priority

1

Priority Number:
2014902194
Priority Date:
10/06/2014
Priority Country:
Australia (AU)

2

Priority Number:
2014902257
Priority Date:
13/06/2014
Priority Country:
Australia (AU)

Classification

IPC classification:
A61K 38/17; A61K 35/545; A61P 29/00;

Publication

European Patent Bulletin

Issue number:
202318
Publication date:
03/05/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages